Krex Pharmaceuticals Inc - San Diego, California 92121

Krex Pharmaceuticals Inc is categorized under Commercial Medical Research in San Diego, CA .

Business Name: Krex Pharmaceuticals Inc
Contact Person: Ying Su
Address: 9823 Pcf Heights Boulevard # F, San Diego, California 92121
Phone Number: (858) 205-3668
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 541712
Share This Business:
Related Businesses: Medivas LLC - San Diego, CA 92121
Acea Biosciences Inc - San Diego, CA 92121
Bio-Quant Inc - San Diego, CA 92121
Cylene Pharmaceuticals - San Diego, CA 92121
Advanced Biodelivery Sciences - San Diego, CA 92121
S K S Ocular LLC - San Diego, CA 92121
Tenova Pharmaceuticals Inc - San Diego, CA 92121
Stemedica Cell Technology - San Diego, CA 92121
Gnf Commercial Systems - San Diego, CA 92121
Sage Bioventures Inc - San Diego, CA 92121
Rempex Pharmaceuticals Inc - San Diego, CA 92121
Biomedica Inc - San Diego, CA 92121
Helicon Therapeutics - San Diego, CA 92121
Celgene Research San Diego - San Diego, CA 92121
Targegen Inc - San Diego, CA 92121
Astute Medical Inc - San Diego, CA 92121

The company Krex Pharmaceuticals Inc provides B2B services in the form of Commercial Medical Research from its single location in California. 1 to 4 employees work for Krex Pharmaceuticals Inc, and the business now earns $100.000 to $499.999 per annum.

Krex Pharmaceuticals Inc was launched in 2005 and is classified under SIC code and category 8731 , and NAICS number and grouping 541712 . To contact Krex Pharmaceuticals Inc, please call Ying Su with the phone number (858) 205-3668 or visit its single location at 9823 Pcf Heights Boulevard # F in San Diego, California 92121.

The location of the single location can also be found using the coordinates 32.899969,-117.189034. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.